These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7521377)

  • 1. Long-term follow-up study of serum IgM antibody to hepatitis C virus (HCV), HCV replication, and liver disease outcome in chronic hepatitis C.
    Quiroga JA; Herrero M; Castillo I; Navas S; Pardo M; Carreño V
    J Infect Dis; 1994 Sep; 170(3):669-73. PubMed ID: 7521377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
    Quiroga JA; van Binsbergen J; Wang CY; Pardo M; Navas S; Trines C; Herrero M; Carreño V
    Hepatology; 1995 Dec; 22(6):1635-40. PubMed ID: 7489967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
    Pawlotsky JM; Darthuy F; Rémiré J; Pellet C; Udin L; Stuyver L; Roudot-Thoraval F; Duvoux C; Douvin C; Mallat A
    J Med Virol; 1995 Nov; 47(3):285-91. PubMed ID: 8551282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.
    Nagayama R; Miyake K; Tsuda F; Okamoto H
    J Med Virol; 1994 Mar; 42(3):311-7. PubMed ID: 7516423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of IgG and IgM HCV antibody secretion in vitro in patients with chronic hepatitis C: correlation with disease activity and response to interferon-alpha.
    Löhr H; Nagel C; Dienes HP; Simpson B; Michel G; Goergen B; Meyer zum Büschenfelde KH; Gerken G
    Hepatology; 1994 Dec; 20(6):1383-9. PubMed ID: 7526999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fluctuations of hepatitis C virus RNA and IgM anti-HCV (core) serum levels correlate with those of alanine aminotransferases during the hepatitis relapses of patients treated with interferon.
    Negro F; Abate ML; Mondardini A; Baldi M; Leandro G; Lombardi S; Wolfe L; Ryff JC; Verme G; Brunetto MR
    J Viral Hepat; 1995; 2(4):171-4. PubMed ID: 7489343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis.
    Saracco G; Abate ML; Baldi M; Calvo PL; Manzini P; Brunetto MR; Oliveri F; Kuo G; Chien D; Houghton M
    Liver; 1994 Apr; 14(2):65-70. PubMed ID: 7515141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha.
    Löhr HF; Elste C; Dienes HP; Michel G; Braun HB; Meyer zum Büschenfelde KH; Gerken G
    J Hepatol; 1996 Sep; 25(3):292-300. PubMed ID: 8895007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum hepatitis C virus (HCV)-RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis.
    Magrin S; Craxì A; Fabiano C; Fiorentino G; Marino L; Almasio P; Pinzello GB; Palazzo U; Vitale M; Maggio A
    J Med Virol; 1992 Nov; 38(3):200-6. PubMed ID: 1283753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C. Comparison of alanine aminotransferase normalization versus loss of HCV RNA and anti-HCV IgM.
    Douglas DD; Rakela J; Lin HJ; Hollinger FB; Taswell HF; Czaja AJ; Gross JB; Anderson ML; Parent K; Fleming CR
    Dig Dis Sci; 1993 Apr; 38(4):601-7. PubMed ID: 8384978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of hepatitis C virus RNA and IgM antibodies to hepatitis C core in chronic hepatitis C.
    Martinelli AL; Brown D; Braun HB; Michel G; Dusheiko GM
    J Hepatol; 1996 Jan; 24(1):21-6. PubMed ID: 8834020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in antibody titers to hepatitis C virus following interferon therapy for chronic infection.
    Urushihara A; Sodeyama T; Matsumoto A; Tanaka E
    J Med Virol; 1994 Apr; 42(4):348-56. PubMed ID: 7519250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus RNA and anti-N14 antibody levels during interferon alpha therapy for chronic hepatitis C.
    Oketani M; Tanaka K; Sho Y; Maeda E; Miyazaki H; Arima T
    Intern Med; 1994 Oct; 33(10):588-92. PubMed ID: 7530068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The diagnostic significance of anti-HCV IgM in chronic hepatitis C viral infection].
    Wu H; Wang J; Lin X
    Zhonghua Nei Ke Za Zhi; 1995 Jan; 34(1):42-5. PubMed ID: 7541329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of immunoglobulin M antibody response to hepatitis C virus core protein in patients with chronic hepatitis C.
    Yuki N; Hayashi N; Ohkawa K; Hagiwara H; Oshita M; Katayama K; Sasaki Y; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1995 Aug; 22(2):402-6. PubMed ID: 7543432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG and IgM core antibodies and viral replication in hepatitis C virus carriers.
    Yuki N; Hayashi N; Hagiwara H; Naito M; Ohkawa K; Katayama K; Kasahara A; Fusamoto H; Kamada T
    J Hepatol; 1994 Jul; 21(1):110-4. PubMed ID: 7525692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short and long-term effects of interferon on serum markers of hepatitis C virus replication.
    Yatsuhashi H; Inoue O; Inokuchi K; Koga M; Nagataki S; Cha TA; Irvine B; Stempien M; Kolberg J; Urdea MS
    J Gastroenterol Hepatol; 1993; 8(1):1-6. PubMed ID: 8382537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM and IgG antibodies to hepatitis C virus in patients with mixed cryoglobulinaemia.
    L'Abbate A; Cutrupi S; Rognetta M; Fabiano C; Craxi A
    Clin Exp Immunol; 1993 Nov; 94(2):313-6. PubMed ID: 7693384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C.
    Shindo M; Di Bisceglie AM; Cheung L; Shih JW; Cristiano K; Feinstone SM; Hoofnagle JH
    Ann Intern Med; 1991 Nov; 115(9):700-4. PubMed ID: 1656828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV replication in mononuclear cells stimulates anti-HCV-secreting B cells and reflects nonresponsiveness to interferon-alpha.
    Löhr HF; Goergen B; Meyer zum Büschenfelde KH; Gerken G
    J Med Virol; 1995 Aug; 46(4):314-20. PubMed ID: 7595407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.